logo
Wuhan Desheng Biochemical Technology Co., Ltd
Sobre nosotros

Wuhan Desheng Biochemical Technology Co., Ltd

Introducción de la empresaWuhan Desheng Biochemical Technology Co., Ltd. fue fundada en 2005, ubicada en Wuhan, China, especializada en I + D, producción y ventas de aditivos para tubos de recolección de sangre y reactivos químicos de homología.Nos dedicamos principalmente a los reactivos de pretratamiento de muestras de sangre, incluida la serie de anticoagulantes: heparina de litio, heparina de sodio, EDTA K2/K3, serie de coagulantes de muestras de sangre:polvo y líquido de acelerador de co...
Ver más
China Wuhan Desheng Biochemical Technology Co., Ltd

2005

Año de creación

10000000 +

Ventas anuales

>100 +

Empleados

Noticias
Hubei Xindesheng Material Technology Co., Ltd. made a heavyweight appearance at the 92nd CMEF
2025-09-26
In the golden September, Yangcheng gathers. From September 26th to 29th, 2025, the global healthcare industry will once again focus on Guangzhou, welcoming the grand opening of the 92nd China International Medical Equipment Fair (CMEF). As an innovative force in the field of core raw materials for in vitro diagnostics (IVD), Hubei Xindesheng Materials Technology Co., Ltd. is ready to go. Led by the company's general manager, an elite team consisting of technical elites and domestic and foreign sales backbones set off from Hubei on September 25th to attend this top-level industry event (booth number: C06 in Hall 20.1), aiming to present a precise diagnostic technology feast to global customers with a series of innovative enzyme preparations and mature core products. 1, Innovation engine: New enzyme preparations make a heavyweight debut, empowering precise diagnosis in new dimensions At this year's CMEF, Xindesheng will launch a new generation of high-purity and highly stable enzyme preparation series that it has carefully developed, including key indicator detection materials such as lactate dehydrogenase (LDH), uricase (UO), creatine kinase isoenzyme (CK-MB), etc. These new products are not only a concentrated reflection of the company's research and development capabilities, but also directly address the higher demand for detection sensitivity, specificity, and inter batch stability in the current IVD testing market. These new enzyme preparations have injected strong power into Xindesheng's "innovation engine", indicating that the company has taken a more solid step on the road of independent research and development of key raw materials, aiming to help downstream reagent manufacturers enhance their product core competitiveness. 2, Stable cornerstone: Core product matrix appears together, showcasing the full chain supply strength While showcasing its innovative edge, Xindesheng will also showcase its traditional core product matrix that has been validated in the market for a long time, demonstrating its comprehensive strength as a reliable supplier. Biological buffering agents, such as Tris, HEPES, Bicine, etc., have excellent purity and provide a stable reaction environment for diagnostic reagents. Chemiluminescent reagents, including luminol and acridine ester luminescent reagents, have the advantages of high luminescence efficiency and sensitive reaction. Chromogenic substrates such as TOOS, TOPS, MAOS, MADB, etc. are sensitive and stable for color development, and are suitable for various enzyme immunoassay analyses. Blood collection tube additives: a full range of products including serum separation gel, anticoagulant, coagulant, silicification agent, etc., provide support for front-end sample processing. New Desheng's product line covers multiple key aspects of IVD reagent development and production, including reaction environment construction, signal generation, and sample preprocessing, demonstrating its strong ability to provide customers with a "one-stop" raw material solution. 3, Face to face communication: Elite teams gather to discuss new chapters of cooperation In this exhibition, Xindesheng not only sent out products, but also a powerful "think tank" and "service team". The general manager, technical experts, and domestic and foreign sales elites gather together to have zero distance and in-depth communication with customers and partners from around the world. Whether it's exploring cutting-edge technology trends, analyzing specific project requirements, or negotiating customized services and international market cooperation, the New Desheng team is fully prepared and looks forward to colliding ideas and listening to market voices on the open platform of CMEF. With more flexible and thoughtful services, we will explore the infinite possibilities of diagnostic technology development together with industry colleagues. Conclusion: At the right time for the grand event, Xindesheng is waiting for your visit in Guangzhou! The exhibition has now grandly opened, and excitement is unfolding! The booth of Hubei Xindesheng is ready, and our team is eagerly awaiting the visit of all new and old friends in Guangzhou with full enthusiasm. Now, by visiting the New Desheng booth (booth number: C06, Hall 20.1), you will be able to: Personally observe and understand the appearance and excellent performance of new enzyme preparations and core products; Face to face with the general manager and technical experts to deeply discuss your customized needs and technical challenges; Obtain the latest product information and cooperation policies. The opportunity is rare, and the grand event is in full swing! We look forward to meeting you in Yangcheng, seeking common development and a win-win future!
Leer más
Latest company news about Hubei Xindesheng Material Technology Co., Ltd. made a heavyweight appearance at the 92nd CMEF
Indian blood collection company visits Hubei Xindesheng to deepen strategic cooperation
2025-09-24
On September 19, 2025, the golden autumn brings a refreshing feeling and the fragrance of osmanthus flowers fills the air. In this beautiful season of harvest and hope, we warmly welcome our important strategic partner from afar - Ms. Anu Moturi, founder of Kriya Medical Technologies (KriyaMed), an Indian blood collection industry enterprise. This visit is a deep interaction between the two sides after embarking on a journey of cooperation, aimed at reviewing the fruitful cooperation process and jointly drawing up a grand blueprint for future development. During the visit, both parties held talks on the in-depth cooperation and future market strategy of EDTA K3 and separation gel, and conducted on-site inspections of our new Huanggang factory. Both sides walked together, sharing their cooperative friendship and seeking common development plans, creating a warm and harmonious atmosphere on site. Under the leadership of founder Anu Moturi, KriyaMed has become an undeniable force in the Indian blood collection tube market. Since establishing a partnership with our company 6-7 years ago, both parties have supported each other and grown together. Ms. Anu Moturi's personal visit this time not only reflects her appreciation for the long-term cooperative relationship with our company, but also demonstrates her firm determination to further deepen cooperation and jointly explore the market. At the beginning of the visit, our company's Chairman Mr. Wang Zhongxi, General Manager Ms. Wang Anqi and other senior leaders expressed their warmest welcome to Ms. Anu Moturi's visit. During the cordial and friendly talks, both sides jointly reviewed the achievements of their cooperation over the past five years. Ms. Anu Moturi expressed her sincere gratitude to our company for providing stable and high-quality product supply, as well as timely and professional technical services. She clearly stated that one of the core objectives of this visit is to explore with our company a more competitive cooperation price for EDTA K3 anticoagulant and core raw material separation gel based on a larger procurement scale in the future, in order to further enhance the competitiveness of KriyaMed products in the Indian market. More notably, Ms. Anu Moturi confidently shared KriyaMed's next strategic development plan. She announced that the company has set clear goals to significantly increase the production capacity and market share of separation gel blood collection tubes, striving to become the leader in the Indian separation gel blood collection tube market. To achieve this ambitious goal, KriyaMed plans to increase its procurement of separation gel from our company on one hand, and on the other hand, invest heavily to enhance its own production capacity. She emphasized that establishing a deeper strategic alliance with our company, a source enterprise with strong technology and production capacity guarantee, is the core cornerstone to achieve this goal. In order to enable our esteemed partners to fully understand our strength and commitment, Mr. Wang Zhongxi, Chairman, and Ms. Wang Anqi, General Manager, personally accompanied Ms. Anu Moturi to visit and inspect our new factory located in Huanggang. On this trip, she not only saw the strong existing production capacity of your company, but also saw the huge development potential for the future. She highly appreciates our company's continuous investment in production capacity and technological upgrades, believing that this provides a solid and reliable guarantee for its future large-scale procurement needs, and is full of confidence in the stability and growth of our long-term cooperation. The successful visit of Ms. Anu Moturi marks a new and deeper stage in our partnership with KriyaMed after five years of testing. From stable suppliers to strategic partners working together, this transformation is based on deep mutual trust and a shared vision. We firmly believe that with Ms. Anu Moturi's outstanding leadership and clear market strategy, the strong alliance between the two parties will bear even more fruitful results. Hubei Xindesheng will spare no effort to support Kriya Medical Technologies in achieving its grand goal of becoming a market leader in India with competitive prices, stable product quality, and a reliable supply chain, and jointly create a mutually beneficial and win-win future!
Leer más
Latest company news about Indian blood collection company visits Hubei Xindesheng to deepen strategic cooperation
The importance of controlling the concentration of MOPS in biological buffering agents
2025-09-22
In life science research, the pH stability of the experimental environment is a core factor affecting cell activity, enzyme catalytic efficiency, and protein structural integrity. As a classic buffer in the neutral to weakly alkaline range, 3- (N-morpholino) propanesulfonic acid (MOPS buffer) is widely used in fields such as cell culture, protein purification, and nucleic acid electrophoresis due to its excellent buffering capacity and biocompatibility. However, the concentration control of MOPS directly determines its buffering efficiency, and improper concentration may cause experimental deviation or even failure. 1, Dynamic balance between concentration and buffering capacity The buffering capacity of MOPS originates from the protonation deprotonation equilibrium between the sulfonic acid groups in its molecular structure and the morpholine ring. When the concentration of hydrogen ions in the solution changes, MOPS maintains pH stability by releasing or absorbing protons. Experiments have shown that the buffering capacity of MOPS is positively correlated with concentration within the range of 10-100 mM. For example, in protein ion exchange chromatography, a 10 mM MOPS buffer may result in a decrease in the separation between target proteins and impurity proteins due to insufficient buffer pairs; And 50 mM MOPS can achieve efficient separation of target proteins under specific elution conditions by precisely regulating the pH value of the mobile phase.But the higher the concentration, the better. When the concentration of MOPS exceeds 200 mM, the number of buffer pairs tends to saturate, and the effect of increasing concentration on pH stability significantly weakens. It may even interfere with the binding of proteins to chromatographic media due to high ion strength. In addition, high concentrations of MOPS may alter the fluidity of lipid membranes, affect the permeability of cell membranes, and thus interfere with the results of cell culture experiments. 2, Concentration sensitive window in cell culture Mammalian cells are extremely sensitive to the pH value of the culture medium, and MOPS, as a commonly used buffer component, should be strictly controlled at a concentration below 20 mM. Research has found that when the concentration of MOPS exceeds 20 mM, the thickness and barrier properties of the surface layer of rat endothelial cells change, resulting in a 15% -20% decrease in the efficiency of glucose uptake by cells. In addition, high concentrations of MOPS may interfere with the differentiation potential of embryonic stem cells by affecting calcium channel activity. 3, Practical points of concentration control Gradient testing method: For specific experimental systems, 5-10 MOPS concentration gradients (such as 5-100 mM) are pre designed, and the optimal concentration is determined by monitoring indicators such as pH stability, cell activity, or protein recovery rate. Compatibility verification: When using new chromatographic media or cell lines, it is necessary to verify the compatibility of MOPS concentration with the experimental system. For example, some metal chelation chromatography media may experience a decrease in performance due to the weak chelation of MOPS. Dynamic adjustment strategy: For long-term experiments (such as continuous cultivation or long-term electrophoresis), the effective concentration of MOPS can be maintained by adding buffer solution in stages to avoid pH loss due to buffer consumption. MOPS concentration control is a key link in the precision of life science experiments. By understanding the quantitative relationship between concentration, buffering capacity, and biological effects, and optimizing the buffering system based on specific experimental requirements, the reliability and reproducibility of experimental results can be significantly improved. In the future, with in-depth research on the interaction mechanism of MOPS molecules, concentration control strategies will become more refined, providing technical support for high-quality development in fields such as biopharmaceuticals and synthetic biology. Desheng is a professional manufacturer of biological buffering agents, established for more than ten years. It has rich experience in research and development, production, and product knowledge, and can provide customers with a large amount of technical support and after-sales guarantee. The biological buffer products currently produced include MOPS, TRIS, HEPES, TAPS, CAPS, BICINE, EPPS, PEP and a series of other biological buffer solutions. If you need them, please feel free to contact us at any time!      
Leer más
Latest company news about The importance of controlling the concentration of MOPS in biological buffering agents
Chemical Stability Analysis of Biological Buffer PIPES
2025-09-19
In biochemical and molecular biology experiments, the stability of buffering agents directly affects the reliability of experimental results. PIPES, as a commonly used biological buffer, has attracted much attention for its chemical stability. The stability of PIPES buffer is particularly outstanding at room temperature and neutral pH environment. In a solid state, it can be stored for several years in a dry place at room temperature after sealing without significant degradation. When in solution state, within its effective buffering range, it can be stabilized for several weeks at 4 ℃ refrigeration and maintained for 1-2 weeks at room temperature. The degradation products are minimal, mainly trace amounts of piperazine derivatives. This provides convenience for experimental operations and reduces the hassle of frequently preparing buffer solutions. The temperature has a significant impact on the stability of PIPES. When heated for a short period of time at 60-80 ℃, its structure is basically stable and can meet the needs of some mild heating experiments. But do not perform high-pressure sterilization, as high temperature and pressure can cause slight decomposition, producing by-products such as piperazine and sulfonic acid. This not only reduces buffering capacity, but may also release trace amounts of harmful substances that affect biological samples, such as cells and enzymes. In terms of lighting, PIPES is relatively stable to ordinary indoor lighting, but long-term exposure to strong light (such as ultraviolet light) may result in slow degradation due to photooxidation. Therefore, the solution needs to be stored in a brown bottle away from light to delay the degradation process. PIPES exhibits good compatibility in interactions with chemical substances. It is relatively stable against common oxidants and not easily oxidized; Not sensitive to reducing agents and can coexist with sulfur-containing reducing agents, suitable for experiments that require a reducing environment, such as protein purification. More importantly, its coordination ability with most metal ions (such as Na ⁺, K ⁺, Ca ² ⁺, Mg ² ⁺) is weak, making it difficult to form stable complexes. This characteristic gives it a significant advantage in reaction systems containing metal ions (such as enzyme reactions and cell culture), and it will not interfere with experiments due to chelation of metal ions. This is a major highlight compared to buffering agents such as BICINE and HEPES. There are three main degradation pathways for PIPES: under strong acidic (pH12) conditions, the bond between the sulfonic acid group and the ethane group may break, releasing sulfonic acid groups and piperazine derivatives; When the temperature exceeds 100 ℃, the piperazine ring may partially open, producing amine and carboxylic acid by-products; Under UV irradiation, it may cause oxidation of the piperazine ring, resulting in the formation of imines or hydroxyl derivatives. Although degradation products are usually not highly toxic, they can reduce buffering capacity and extreme conditions should be avoided. In practical applications, controlling stability is crucial. The solution is recommended to be prepared and used immediately. If storage is required, it can be adjusted to pH 6.5-7.0, stored at 4 ℃ in the dark, and avoid repeated freezing and thawing. If aseptic treatment is required, 0.22 μ m filter membrane can be used for filtration. Meanwhile, PIPES can coexist with most salts, low concentration organic solvents (such as ethanol, DMSO), and biological reagents (enzymes, proteins) without worrying about stability conflicts. In summary, PIPES exhibits excellent chemical stability under conventional experimental conditions and is widely used in biological systems. As long as the storage and usage conditions are reasonably controlled, its buffering performance can be fully utilized, providing reliable guarantees for biological experiments. Since the establishment of Desheng, we have always adhered to the core values of "service first". For product after-sales, we have an elite after-sales team who not only meticulously track and follow up on customer feedback information, but also provide professional product technical guidance. In addition, we highly value every suggestion and opinion from our customers and actively adopt them to continuously optimize our services. Therefore, if you are looking for high-quality biological buffering agents, Desheng is undoubtedly your trusted choice, and we promise to do our best to meet your expectations.
Leer más
Latest company news about Chemical Stability Analysis of Biological Buffer PIPES
¿Qué dijeron?
tony
tony
¡Como distribuidor del agente del hospital, sus añadidos del tubo de la colección de la sangre son mismo traje para mis necesidades, yo piensan que tenemos establecer un buen negocio con uno a, gracias!
¡Como distribuidor del agente del hospital, sus añadidos del tubo de la colección de la sangre son mismo traje para mis necesidades, yo piensan que tenemos establecer un buen negocio con uno a, gracias!
William
William
Recibí la orden de muestra y pasé la prueba. Gracias por todos sus esfuerzos. Usted es un socio confiable! Continuaremos cooperando con usted en el futuro.
Recibí la orden de muestra y pasé la prueba. Gracias por todos sus esfuerzos. Usted es un socio confiable! Continuaremos cooperando con usted en el futuro.
El marinel
El marinel
El amortiguador biológico producido por Desheng Company tiene una alta pureza, buena solubilidad en agua y una apariencia de polvo blanco.nos ayuda a usar el amortiguador biológico de manera correcta y eficiente¡Fue una experiencia muy buena, esperamos la próxima colaboración!
El amortiguador biológico producido por Desheng Company tiene una alta pureza, buena solubilidad en agua y una apariencia de polvo blanco.nos ayuda a usar el amortiguador biológico de manera correcta y eficiente¡Fue una experiencia muy buena, esperamos la próxima colaboración!
Envíe su consulta
Envíenos su solicitud y le responderemos lo antes posible.
Envío